EMA Authorised: Protopic (tacrolimus) — LEO Pharma A/S

View source ↗

Summary

The European Medicines Agency has authorised Protopic (tacrolimus) by LEO Pharma A/S for the treatment of atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Protopic (tacrolimus)

Snippet

Status: Authorised. Therapeutic area: Dermatitis, Atopic. MAH: LEO Pharma A/S. Decision date: 02/12/2025